News

Published on 10 Dec 2024 on Investor's Business Daily

NewAmsterdam Pharma Soars 41% On A Surprise Benefit From Cholesterol Drug


Article preview image

Biotech Stock: Promising LDL Reduction NewAmsterdam tested obicetrapib in patients who don't have...

NASDAQ.SNY price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
SNY's Tolebrutinib Gets FDA Breakthrough Therapy Tag for nrSPMS

Sanofi SNY announced that the FDA has granted a Breakthrough Therapy designation to its...

Zacks · via Yahoo Finance 13 Dec 2024

Why Is Novavax (NVAX) Up 13.6% Since Last Earnings Report?

It also anticipates a portion of the costs of both these years to be reimbursed by Sanofi. How Ha...

Zacks · via Yahoo Finance 12 Dec 2024

GSK Stock Declines 20% in 3 Months: Should You Buy, Sell or Hold?

Free Report) stock has declined 20.2% in the past three months compared with a decrease of 12.3% ...

Zacks 11 Dec 2024

FDA Grants Fast Track Tag to SNY's Two COVID & Flu Vaccine Candidates

Sanofi SNY announced that the FDA has granted a Fast Track designation to two combination vaccine...

Zacks · via Yahoo Finance 11 Dec 2024

NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines

Novavax, Inc. Price Novavax, Inc. price | Novavax, Inc. Quote NVAX’s Zacks Rank Novavax currently...

Zacks · via Yahoo Finance 11 Dec 2024

NewAmsterdam Pharma Soars 41% On A Surprise Benefit From Cholesterol Drug

Biotech Stock: Promising LDL Reduction NewAmsterdam tested obicetrapib in patients who don't have...

Investor's Business Daily 10 Dec 2024

Top-3 International Stocks Beating Their U.S. Peers for Dividend Earnings

While U.S. stocks are often among the most popular for dividend investors, there is considerable...

TheStreet.com 6 Dec 2024

Why Is Denali Therapeutics (DNLI) Down 21.2% Since Last Earnings Report?

Following the exact same course, the stock was allocated a grade of F on the value side, putting ...

Zacks · via Yahoo Finance 6 Dec 2024

Denali Starts Dosing in Phase II Parkinson's Disease Study

DNLI begins dosing in the phase IIa study on BIIB122 in approximately 50 participants with...

Zacks · via Yahoo Finance 6 Dec 2024

Novavax to Sell Czech Manufacturing Plant to Novo Nordisk for $200M

NVAX intends to use the payment from Novo to advance the development of its vaccine pipeline. The...

Zacks · via Yahoo Finance 5 Dec 2024